Log in to save to my catalogue

Therapeutic potential of histamine H4 receptor antagonist as a preventive treatment for diabetic ret...

Therapeutic potential of histamine H4 receptor antagonist as a preventive treatment for diabetic ret...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e057b41357284768b4a61dddc1045013

Therapeutic potential of histamine H4 receptor antagonist as a preventive treatment for diabetic retinopathy in mice

About this item

Full title

Therapeutic potential of histamine H4 receptor antagonist as a preventive treatment for diabetic retinopathy in mice

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-09, Vol.14 (1), p.22664-10, Article 22664

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Diabetic retinopathy (DR) is a prevalent complication of diabetes, often resulting in vision loss and blindness. Existing treatments primarily aim to control blood sugar levels and inhibit angiogenesis. However, current therapies for DR, such as anti-VEGF and laser photocoagulation, are frequently invasive, and can cause adverse side effects. Conse...

Alternative Titles

Full title

Therapeutic potential of histamine H4 receptor antagonist as a preventive treatment for diabetic retinopathy in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e057b41357284768b4a61dddc1045013

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e057b41357284768b4a61dddc1045013

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-72166-9

How to access this item